All Issue

2022 Vol.52, Issue 1 Preview Page

Original Article

31 March 2022. pp. 20-27
Abstract
References
1

Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 2018;16:368-81.

10.1038/s41579-018-0005-429626210
2

Nasri D, Bouslama L, Pillet S, Bourlet T, Aouni M, Pozzetto B. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev Mol Diagn 2007;7:419-34.

10.1586/14737159.7.4.41917620049
3

Rhoades RE, Tabor-Godwin JM, Tsueng G, Feuer R. Enterovirus infections of the central nervous system. Virology 2011;411:288-305.

10.1016/j.virol.2010.12.01421251690PMC3060663
4

Tapparel C, Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol 2013;14:282-93.

10.1016/j.meegid.2012.10.01623201849
5

Razavi SM, Zahri S, Zarrini G, Nazemiyeh H, Mohammadi S. Biological activity of quercetin-3-O-glucoside, a known plant flavonoid. Bioorg Khim 2009;35:414-6.

10.1134/S106816200903013319621057
6

Lalani S, Poh CL. Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71). Viruses 2020;12:184.

10.3390/v1202018432041232PMC7077323
7

Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci 2016;5:e47.

10.1017/jns.2016.4128620474PMC5465813
8

Song JH, Ahn JH, Kim SR, Cho S, Hong EH, Kwon BE, et al. Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway. Sci Rep 2019;9:9413.

10.1038/s41598-019-45868-831253850PMC6599049
9

Wong G, He S, Siragam V, Bi Y, Mbikay M, Chretien M, et al. Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection. Virol Sin 2017;32:545-7.

10.1007/s12250-017-4057-928884445PMC6598929
10

Nile SH, Kim DH, Nile A, Park GS, Gansukh E, Kai G. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening. Food Chem Toxicol 2020;135:110985.

10.1016/j.fct.2019.11098531765700
11

Badran SA, Midgley S, Andersen P, Böttiger B. Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. Scand J Infect Dis 2011;43:642-8.

10.3109/00365548.2011.57709421526904
12

Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007;356:1226-34.

10.1056/NEJMoa06595417377160
13

Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 2004;78:7916-24.

10.1128/JVI.78.15.7916-7924.200415254164PMC446098
14

Lin YW, Wang SW, Tung YY, Chen SH. Enterovirus 71 infection of human dendritic cells. Exp Biol Med 2009;234:1166-73.

10.3181/0903-RM-11619596831
15

Villa TG, Feijoo-Siota L, Rama JLR, Ageitos JM. Antivirals against animal viruses. Biochem Pharmacol 2017;133:97-116.

10.1016/j.bcp.2016.09.02927697545PMC7092833
16

Pelly S, Liotta D. Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines. ACS Cent Sci 2021;7:396-9.

10.1021/acscentsci.1c0025833786374PMC7945585
17

Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis 1978;137:122-30.

10.1093/infdis/137.2.122627734
18

Lampis G, Ingianni A, Pompei R. Synergistic effects of triterpenic compounds with prostaglandin A1 on vaccinia virus infected L929 cells. Antiviral Res 1997;36:191-5.

10.1016/S0166-3542(97)00051-X
19

Cutting WC, Dreisbach RH, Neff BJ. Antiviral chemotherapy; flavones and related compounds. Stanford Med Bull 1949;7:137.

20

Kuroya M, Ishida N, Konno J, Shiratori T, Miura M, Yoshinari Y. Antiviral activity of several quinone and isoquinoline derivatives. Yokohama Med Bull 1953;4:73-7.

21

Nile A, Nile SH, Shin J, Park G, Oh JW. Quercetin-3-Glucoside Extracted from Apple Pomace Induces Cell Cycle Arrest and Apoptosis by Increasing Intracellular ROS Levels. Int J Mol Sci 2021;22:10749.

10.3390/ijms22191074934639090PMC8509831
22

Choi HJ, Song JH, Kwon DH. Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice. Phytother Res 2012;26:462-4.

10.1002/ptr.352921728202
23

Song JH, Park KS, Kwon DH, Choi HJ. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa. J Med Food 2013;16:274-9.

10.1089/jmf.2012.229023566054
24

Choi HJ, Song JH, Park KS, Kwon DH. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci 2009;37:329-33.

10.1016/j.ejps.2009.03.00219491023
25

Choi HJ, Kim JH, Lee CH, Ahn YJ, Song JH, Baek SH, et al. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res 2009;81:77-81.

10.1016/j.antiviral.2008.10.00218992773PMC7114206
26

Kwon DH, Ji JH, Yim SH, Kim BS, Choi HJ. Suppression of influenza B virus replication by sakuranetin and mode of its action. Phytotherapy Res 2018;32:2475-9.

10.1002/ptr.618630187587
27

Choi HJ. In Vitro Antiviral Activity of Sakuranetin against Human Rhinovirus 3. Osong Public Health Res Perspect 2017;8:415-20.

10.24171/j.phrp.2017.8.6.0929354400PMC5749483
Information
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • Volume : 52
  • No :1
  • Pages :20-27
  • Received Date : 2022-02-04
  • Revised Date : 2022-03-12
  • Accepted Date : 2022-03-23